The Neurotechnology Industry Organization works with K&L Gates to represent the policy and advocacy interests of the neurotechnology industry in Washington. Working together, NIO members and our strategic partners we will be focusing on the following areas:
NIO provides a unified policy voice in Washington, D.C. and takes the lead with local, national and international governments to highlight ways to encourage the growth of neurotechnology. In support of NIO's public policy objectives, NIO hosts an annual public policy tour in Washington DC each spring which brings neurotech executives face to face with elected officials and regulators to discuss ways to encourage neurotech innovation and industry growth. See 2012 NIO policy tour fly-in review.
NIO aggressively advocates in Congress and White House for important member issues such as tax reform for neurotech research and investment, as well as Medicare coverage for neuropharmaceuticals, neurodevices and neurodiagnostics. In 2012, we are working on developing Neurodegenerative Drug Incentive Initiative. Previously, NIO spearheaded the creation of the National Neurotechnology Initiative (NNTI), a federal research and development programmed aimed at accelerating translational innovation and near-term growth across the neurotech industry.
NIO develops position papers, analyzes legislation, provides expert testimony to federal, state and local political leaders and regulators, and aids in the development of regional neurotechnology centers.